±èÁÖÇ×
¾ÏÁ¤¹ÐÀÇ·á¼¾ÅÍÀå
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : Æó¾Ï, µÎ°æºÎ¾Ï, ½Äµµ¾Ï
Á÷
ˤ
: ±³¼ö(¾ÏÁ¤¹ÐÀÇ·á¼¾ÅÍÀå)
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
14
ÇØ¿Ü
Evaluation of E1b gene-attenuated replicating adenoviruses for cancer gene therapy
13
±¹³»
Æó¾Ï¿¡ ÀÇÇÑ ¾Ç¼º È丷»ïÃâȯÀÚ¿¡¼ OK-432¿Í Doxycycline È丷À¯Âø¼úÀÇ ºñ±³
12
ÇØ¿Ü
Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor
11
±¹³»
Evaluation of E1B-mutant replicating adenoviruses for cancer gene therapy
10
ÇØ¿Ü
Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck.
9
±¹³»
CD5¿Í Cytokeratin 7¿¡ À½¼ºÀÌ°í Cytokeratin 13¿¡ ¾ç¼ºÀÎ Èä¼± ÆíÆò»óÇǼ¼Æ÷¾Ï 1¿¹
8
±¹³»
Anthracycline ÀÇ Ä¡·á·ÂÀÌ ÀÖ´Â ÀüÀ̼º À¯¹æ¾Ï¿¡ ´ëÇÑ Docetaxel ÀÇ Á¦ 2 »ó ´Ù±â°ü ÀÓ»ó½ÃÇè
7
ÇØ¿Ü
Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells
6
±¹³»
ÁøÇ༺ ¾Ç¼ºÁ¾¾ç ȯÀÚ¿¡¼ ÈÇпä¹ý ÈÄ ¹ß»ýÇÑ È£Áß±¸ °¨¼ÒÁõ¿¡ ´ëÇÑ Leukokine (Filgrastim, °íG-CSF) ÀÇ À¯È£¼º ¹× ¾ÈÀü¼ºÀ» Æò°¡Çϱâ À§ÇÑ ¹«ÀÛÀ§ ¼±Á¤ Ÿ ¾à¹° ºñ±³ °ø°³ Á¦ III»ó ÀÓ»ó½ÃÇè.
5
±¹³»
E1B 55kD À¯ÀüÀÚ °á¼Õ ¾Æµ¥³ë¹ÙÀÌ·¯½ºÀÇ Á¾¾ç ƯÀÌ Áõ½Ä ¹× »ì»ó´É °ËÁõ.
11
12
13
14
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729